赖氨酸
生物
癌症研究
肝细胞癌
组蛋白
基因
生物化学
氨基酸
作者
Junhu Wan,Hongyang Li,Liang Ming
标识
DOI:10.1016/j.biopha.2018.12.148
摘要
Lysine crotonylation is a new posttranslational modification (PTM) type identified on histones, which is enriched on active gene promoters or potential enhancers in mammalian cell genomes. However, the function of lysine crotonylation in the cancer process is not known. Intriguingly, we found that lysine crotonylation expression is down-regulated in liver, stomach, kidney carcinomas, and up-regulated in thyroid, esophagus, colon, pancreas and lung carcinomas. In hepatocellular carcinoma (HCC), lysine crotonylation expression is correlated with Tumour, Node, and Metastasis (TNM) stage. Besides, the crotonylation level is increased by knocking down HDACs or adding HDACs inhibitor, TSA, and thus inhibits hepatoma cell motility and proliferation. Taken together, our findings opened up a new field for the investigation and understanding of the biological role of lysine crotonylation.
科研通智能强力驱动
Strongly Powered by AbleSci AI